December 1st, 2017
•The presented protocols describe how to perform a hemagglutination inhibition assay to quantify influenza-specific antibody titers from serum samples of influenza vaccine recipients. The first assay determines optimal viral antigen concentrations by hemagglutination. The second assay quantifies influenza-specific antibody titers by hemagglutination inhibition.
Related Videos
Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
An in vivo Assay to Test Blood Vessel Permeability
Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model
A Sensitive Method to Quantify Senescent Cancer Cells
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method
An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse
Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved